Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injection) Iodine-123-Metaiodobenzylguanidine (123I-mIBG) scintigraphy has been proven to be effective in early differential diagnosis for Lewy body disease. But early imaging (15-30 min after injection) has only been marginally studied for its possible diagnostic role. In this prospective study a thresholdfor the early Heart-to-Mediastinum (H/M) count ratio has been investigated, obtaining a diagnostic accuracy analogous to conventional, delayed imaging
Purpose: Cardiac [123I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic c...
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
Background: Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
International audienceBACKGROUND: Different studies have found diminished cardiac metaiodobenzylguan...
Purpose: To provide reliable and reproducible heart/mediastinum (H/M) ratio cut-off values for parki...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Objective: This study investigates the effects of manual and semi-automatic methods for assessing MI...
The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a ...
The use of 123I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a p...
PURPOSE: Cardiac [(123)I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic...
Objective(s): We recently developed a new uptake index method for123I-metaiodobenzylguanidine (123I-...
Purpose: Cardiac [123I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic c...
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
Background: Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h...
Early diagnosis of Parkinson's disease (PD) is of primary importance. The delayed (3-4 h after injec...
International audienceBACKGROUND: Different studies have found diminished cardiac metaiodobenzylguan...
Purpose: To provide reliable and reproducible heart/mediastinum (H/M) ratio cut-off values for parki...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Objective: This study investigates the effects of manual and semi-automatic methods for assessing MI...
The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a ...
The use of 123I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a p...
PURPOSE: Cardiac [(123)I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic...
Objective(s): We recently developed a new uptake index method for123I-metaiodobenzylguanidine (123I-...
Purpose: Cardiac [123I]metaiodobenzylguanidine scintigraphy (123I-MIBG), reflecting postganglionic c...
Copyright: © 2014 Miyazaki Y, et al. This is an open-access article distributed under the terms of ...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...